Structural biochemistry. 17. Synthesis of tryptophan dipeptides

Area of Science:

• Biochemistry
• Pharmacology
• Oncology

Background:

• Leukemia, specifically lymphocytic leukemia in mice, poses a significant challenge in cancer research.
• Identifying novel therapeutic agents with potent anti-leukemia activity is crucial for developing effective cancer treatments.

Purpose of the Study:

• To investigate the anti-leukemia activity of Boc-Trp-Leu hydrazide against L-1210 and P388 murine lymphocytic leukemias.
• To synthesize and evaluate related tryptophan dipeptides for their potential to inhibit leukemia cell growth.

Main Methods:

• Synthesis of Boc-Trp-Leu hydrazide and a series of related tryptophan dipeptides.
• In vitro assessment of the inhibitory effects of these compounds on L-1210 and P388 leukemia cell lines.
• Utilizing the DCCI-NHS peptide bond-forming procedure for efficient dipeptide synthesis.

Main Results:

• Boc-Trp-Leu hydrazide demonstrated significant inhibition of L-1210 and P388 murine lymphocytic leukemia cell growth.
• Related tryptophan dipeptides were found to be devoid of significant anti-leukemia activity.
• The DCCI-NHS method proved to be a convenient approach for preparing these tryptophan dipeptides.

Conclusions:

• Boc-Trp-Leu hydrazide exhibits potent anti-leukemia properties against specific murine models.
• The observed activity is structure-specific, as related dipeptides lack similar efficacy.
• The DCCI-NHS coupling method is an effective synthetic strategy for generating potential anti-cancer dipeptides.